BOLDEN African News · Tuesday 17 November 2026
Zambia breaks ground on its first cholera vaccine plant in Lusaka
Construction of the ZAMVAX oral cholera vaccine plant began on 17 November in the Lusaka South Multi-Facility Economic Zone. ZAMVAX is a 60-40 joint venture between Zambia's Industrial Development Corporation and China's Jijia International Medical Technology Company. The first phase is a fill-and-finish facility with annual capacity of up to 20 million doses using imported bulk vaccine, with local antigen production planned later; no investment figure was disclosed.
Why it matters
Local fill-and-finish capacity could cut Zambia's reliance on imported cholera vaccine and the supply delays that come with it.
Sources: Zambia Monitor, Xinhua · 17 November 2026
